- Lilly’s oral GLP-1, orforglipron, superior to oral semaglutide in head-to-head trial Eli Lilly and Company
- Eli Lilly’s obesity pill outperforms Novo Nordisk’s oral drug in head-to-head diabetes trial CNBC
- Daily weight loss pill can help cut body weight by a fifth, trial shows The Guardian
- Lilly’s Obesity Pill Will Have Far-Reaching Effect, Doctors Say Bloomberg.com
- Lilly weight-loss pill could be FDA-approved by year-end Reuters
Source link
